Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LARC vs SARC for unintended pregnancy prevention
NCT01299116Phase 4Completed
- Sponsor
- FHI 360
- Start
- Dec 2011
- Primary completion
- Jun 2016
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of avatrombopag, TCu 380A, etonogestrel in pregnancy, sponsored by FHI 360. Started Dec 2011; status: completed.
02
Drugs
avatrombopagTCu 380Aetonogestrel
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT01299116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299116.